About Hytanbio-Tech | Research & OEM Projects

Research and manufacturing background

Hytanbio-Tech was founded in Hong Kong in 2026 as a biological research and development entity supporting international business expansion. Its in-house commercial manufacturing base was established in 2014 in Shaoxing, Mainland China. According to the company profile, the research center covers more than 4,000 square meters and supports multiple peptide production lines with large-scale synthesizers, analytical and preparative HPLC systems, and laboratories built to GMP standards. The company reports an ISO 9001:2015 quality management system. Its core portfolio includes cosmetic-grade peptide raw materials, lyophilized peptide powder, dissolvable microneedle patches and dissolvable oral films. These company capabilities provide context for project discussions; they do not by themselves establish the performance or market authorization of an injection pen. Device-specific evidence is reviewed against the exact proposed configuration and application.

From feasibility to a defined project

The company’s stated service model connects formulation feasibility, prototype sampling, specification confirmation, batch documentation and export coordination. It serves skincare brands, cosmetic laboratories, beauty institutions and cross-border distributors with cosmetic-oriented development and manufacturing support. This website provides a dedicated entry point for injection pen OEM and ODM project inquiries. The initial discussion clarifies the intended application, technical requirements and responsibilities before a scope is proposed. Cosmetic-grade materials are not represented as injectable-grade medicines, and company-level quality credentials are not presented as universal medical device approvals. For an injection device program, buyers should request the applicable documentation for the responsible entity, manufacturing site and device configuration. Our team uses the project brief to identify what is available, what needs development and which questions require further technical or regulatory review.

How injection pen projects are scoped

Hytanbio-Tech is the contact point for the injection pen OEM and ODM inquiries submitted through this website. A project starts by identifying the requested device format, customization, quantities and destination market. The supplied company profile describes peptide research and cosmetic delivery-system capabilities, while an injection pen program needs a separate scope for device design, component sourcing, assembly, filling, testing and release. Buyers can use the responsibility matrix below to name the entity performing each activity and the evidence it will provide. Activities performed internally or by partners are confirmed in the written project proposal; this website does not assign an unverified production role to a particular facility. Existing sample photographs help discuss exterior finish and assembly interfaces. The commercial agreement should then identify the legal entities, controlled device configuration, deliverables and approval owners before samples or bulk supply are committed.

Project responsibility matrix
Activity	Owner to identify	Document to request
Project intake and commercial scope	Hytanbio-Tech contact team; proposal identifies contracting entity	Requirements record and written quotation
Device design and component sourcing	Activity owner to be named in proposal	Controlled drawings and supplier responsibilities
Assembly and packaging	Site and operator to be named in proposal	Process scope and configuration traceability
Formulation and filling	Responsible project entities to be confirmed	Formulation, container and filling scope
Testing and release	Evidence owner and release approver to be confirmed	Applicable reports and approval records
Destination-market responsibilities	Responsible entity to be confirmed for the presentation	Labeling, market-status and distribution scope